Yes this segment is very small in the overall business. But after the demerger, this will become part of Piramal Healthcare script.
Nandini Piramal has big plans for the Consumer healthcare division, and Saridon was one of their trump cards.
They fought hard to take it out from the banned list of medicines.
And they had plans to release brand extensions.
Disc. Invested. Highly interested in Piramal Healthcare. Appreciate the financial vertical too, but maybe will keep only the healthcare vertical after the demerger.